2018 Advocacy Awards

The October 2017 Research Advocate is now online . Highlights from this month's issue: A former congressional leader who was instrumental in doubling the National Institutes of Health (NIH) budget, the head of a global research center aimed at reducing the burden of disease, two long-time mental health advocates dedicated to accelerating research, a rare disease organization committed to biotech innovation, and a world-renowned vaccine researcher are among those who will be honored at Research!America’s 22 nd annual Advocacy Awards on Wednesday, March 14, 2018 , in Washington, D.C. Research and education are key to addressing the complexities of the opioid epidemic. “On the research side,...
Dear Research Advocate, During a visit today to Augusta University, which is home to the former Medical College of Georgia, I heard grad students distill their multiple-hour thesis presentations into 3 minutes. You may be familiar with the “ 3MT ” concept, but this was my first experience of it. What a terrific grounding for researchers who want to engage in public outreach and advocacy! I also heard-- not for the first time-- that grad students in science want communications training, but rarely receive it. More widespread adoption of 3MT would undoubtedly help bridge that gap. During a House Labor-H Subcommittee hearing this week focused on NIH, champions from both sides of the aisle...
Dear Research Advocate, I’m sure you’ve heard that the House passed an ACA replacement bill today. In addition to the significant implications for health care access, the bill would repeal the medical device tax and, tragically, eliminate the Prevention and Public Health Fund. As written, this bill likely cannot pass the Senate. Beyond that, the only bet I would take when it comes to repeal/replace is that there are no safe bets... On to research funding: After months and months of hard work by Congress and advocates, an FY17 appropriations deal providing a $2 billion increase for NIH and modest increases for NSF and FDA is on track to become law. While the news is not 100% positive (e.g...

Sidebar Quote

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient